... the same time, Medicare is cutting back on the amount of payment it allows. Can anyone provide additional info on this situation?
Yes, that is correct.
Sanofi-Aventis signed settlement agreements in April, 2010 with Teva, APP, Sandoz, Hospira, and Sun Pharmaceuticals requiring the companies to stop selling unauthorized generic oxaliplatin products from June 30, 2010 to August 9, 2012.
Sanofi-Aventis has Eloxatin (oxaliplatin) 5 mg/mL available in 10 mL , 20ml and 40ml vials.
- Oxaliplatin Information for Consumers
- Oxaliplatin Information for Healthcare Professionals (includes dosage details)
- Side Effects of Oxaliplatin (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 21 Sep 2009 • 1 answer
Posted 5 Oct 2009 • 1 answer
Posted 24 Apr 2012 • 1 answer
Posted 31 May 2013 • 3 answers
Posted 23 Jan 2014 • 1 answer